paroxetine has been researched along with Inflammation in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 9 (69.23) | 24.3611 |
2020's | 3 (23.08) | 2.80 |
Authors | Studies |
---|---|
Bairlein, M; Bräuer, N; Dahllöf, H; Hillig, RC; Klint, J; Laux-Biehlmann, A; Mesch, S; Neagoe, I; Nubbemeyer, R; Puetter, V; Schulz, S; Steinmeyer, A; Ter Laak, A; Werner, S; Zollner, TM | 1 |
Chen, H; Cui, Z; Gao, Z; Hong, J; Li, X; Ma, Y; Ning, L; Tong, T; Wang, X; Wang, Z; Xuan, B; Yan, Y | 1 |
Gu, J; Ji, G; Song, F; Wu, L; Wu, W; Zhu, Y | 1 |
Nasrallah, HA; Sagarwala, R | 1 |
He, JH; Hou, NN; Huang, CP; Ji, SY; Zhang, CN; Zhang, HQ; Zhang, X; Zhu, JH; Zhu, LB | 1 |
Hsu, BG; Hu, TM; Lee, RP; Lin, NT; Subeq, YM; Yang, FL | 1 |
Fujimori, K; Sato, K; Sekino, Y; Shigemoto-Mogami, Y; Suzuki, T; Takaki, J | 1 |
Assies, J; Koeter, MWJ; Mocking, RJT; Nap, TS; Ruhé, HG; Schene, AH; Vaz, FM; Westerink, AM | 1 |
Colado, MI; Izco, M; Llopis, N; O'Shea, E; Orio, L; Torres, E | 1 |
Chung, YC; Jin, BK; Kim, SR | 1 |
Hannestad, J | 1 |
Jun, IG; Kim, SH; Lee, BS; Park, JY | 1 |
Ikeda, S; Jiang, J; Kuhara, T; Ogawa, H; Suto, H; Ueki, R; Zheng, Y | 1 |
1 review(s) available for paroxetine and Inflammation
Article | Year |
---|---|
Changes in inflammatory biomarkers before and after SSRI therapy in PTSD: A review.
Topics: Biomarkers; Humans; Hydrocortisone; Inflammation; Interleukin-1beta; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 2019 |
12 other study(ies) available for paroxetine and Inflammation
Article | Year |
---|---|
Discovery and Characterization of the Potent and Selective P2X4 Inhibitor
Topics: Acetamides; Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Drug Discovery; Enzyme Induction; Female; Gene Expression Regulation; Humans; Inflammation; Ligands; Male; Mice; Mice, Inbred C57BL; Pain; Purinergic P2X Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P2X4 | 2019 |
Identification and investigation of depression-related molecular subtypes in inflammatory bowel disease and the anti-inflammatory mechanisms of paroxetine.
Topics: Anti-Inflammatory Agents; Antidepressive Agents; Depression; Humans; Inflammation; Inflammatory Bowel Diseases; Paroxetine; Tumor Necrosis Factor Inhibitors | 2023 |
Paroxetine induced larva zebrafish cardiotoxicity through inflammation response.
Topics: Animals; Cardiotoxicity; Embryo, Nonmammalian; Inflammation; Larva; Paroxetine; T-Box Domain Proteins; Water Pollutants, Chemical; Zebrafish; Zebrafish Proteins | 2023 |
Paroxetine suppresses reactive microglia-mediated but not lipopolysaccharide-induced inflammatory responses in primary astrocytes.
Topics: Animals; Astrocytes; Cell Line; Humans; Inflammation; Interleukin-1beta; Lipopolysaccharides; Mice; Microglia; Nitric Oxide Synthase Type II; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tumor Necrosis Factor-alpha | 2020 |
The use of a selective serotonin reuptake inhibitor decreases heavy alcohol exposure-induced inflammatory response and tissue damage in rats.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cytokines; Enzymes; Ethanol; Inflammation; Interleukin-6; L-Lactate Dehydrogenase; Liver; Lung; Male; Pancreas; Paroxetine; Rats; Selective Serotonin Reuptake Inhibitors; Tumor Necrosis Factor-alpha | 2013 |
Paroxetine prevented the down-regulation of astrocytic L-Glu transporters in neuroinflammation.
Topics: Amino Acid Transport System X-AG; Antidepressive Agents; Astrocytes; Cells, Cultured; Down-Regulation; Glutamic Acid; Humans; Inflammation; Lipopolysaccharides; Microglia; Neurons; Paroxetine | 2015 |
Biological profiling of prospective antidepressant response in major depressive disorder: Associations with (neuro)inflammation, fatty acid metabolism, and amygdala-reactivity.
Topics: Adult; Amygdala; Antidepressive Agents; C-Reactive Protein; Depressive Disorder, Major; Fatty Acids; Female; Humans; Inflammation; Lipid Metabolism; Magnetic Resonance Imaging; Male; Middle Aged; Paroxetine; Prospective Studies | 2017 |
A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons.
Topics: Animals; Drug Administration Schedule; Fever; Frontal Lobe; Hypothalamus; Inflammation; Interleukin-1beta; Male; Microglia; Minocycline; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; NF-kappa B; Paroxetine; Radioligand Assay; Rats; Rats, Inbred Strains; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2010 |
Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antidepressive Agents, Second-Generation; Blotting, Western; Brain; Dopamine; Enzyme Activation; Immunohistochemistry; Inflammation; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Motor Activity; NADPH Oxidases; Neurons; Nitric Oxide Synthase Type II; Oxidative Stress; Parkinson Disease, Secondary; Paroxetine; Peroxidase; Reverse Transcriptase Polymerase Chain Reaction; Substantia Nigra; Tumor Necrosis Factor-alpha | 2010 |
Comment on "Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease".
Topics: Animals; Anti-Inflammatory Agents; Brain; Citalopram; Encephalitis; Humans; Inflammation; Lipopolysaccharides; Mice; Nerve Degeneration; Neurons; Oxidative Stress; Parkinsonian Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2010 |
Interaction of morphine and selective serotonin receptor inhibitors in rats experiencing inflammatory pain.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Citalopram; Disease Models, Animal; Hyperalgesia; Inflammation; Injections, Spinal; Male; Morphine; Pain; Pain Measurement; Pain Threshold; Paroxetine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Temperature; Time Factors | 2012 |
Inhibitory effects of paroxetine on the development of atopic dermatitis-like lesions in NC/Nga mice.
Topics: Administration, Oral; Animals; Antipruritics; Dermatitis, Atopic; Disease Models, Animal; Female; Inflammation; Mice; Mice, Transgenic; Paroxetine; Selective Serotonin Reuptake Inhibitors; Skin; Time Factors | 2007 |